Compare NRC & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NRC | MASS |
|---|---|---|
| Founded | 1981 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 278.8M | 324.4M |
| IPO Year | N/A | 2020 |
| Metric | NRC | MASS |
|---|---|---|
| Price | $15.85 | $6.68 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 90.7K | ★ 425.8K |
| Earning Date | 01-26-2026 | 11-10-2025 |
| Dividend Yield | ★ 4.03% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.71 | N/A |
| Revenue | ★ $139,102,000.00 | $65,045,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $19.55 |
| P/E Ratio | $22.35 | ★ N/A |
| Revenue Growth | N/A | ★ 36.21 |
| 52 Week Low | $9.76 | $1.81 |
| 52 Week High | $19.94 | $9.34 |
| Indicator | NRC | MASS |
|---|---|---|
| Relative Strength Index (RSI) | 49.78 | 51.66 |
| Support Level | $15.90 | $5.88 |
| Resistance Level | $16.53 | $6.64 |
| Average True Range (ATR) | 0.73 | 0.37 |
| MACD | -0.24 | 0.15 |
| Stochastic Oscillator | 7.88 | 97.92 |
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.